Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERPRIM: Strategies in Acute Primary HIV Infection
NCT00196638Phase 3Terminated
- Sponsor
- ANRS
- Start
- May 2002
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
01
Overview
A Phase 3 trial of peginterferon alfa-2b in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started May 2002; status: terminated.
02
Drugs
peginterferon alfa-2b
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00196638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196638.